DAEWOONG PHARMA Response to report on selling control of affiliate INTherapeutics: nothing decided
DAI summary · Not investment advice
Daewoong Pharmaceutical said it is reviewing a report on selling control of affiliate IN Therapeutics but nothing is decided, and will update by December 11, 2026.
Key facts
- Clarification type
- Unconfirmed
- Report
- Daewoong Pharmaceutical reportedly pursuing sale of management control of its new-drug development affiliate Inno Therapeutics
- Company statement
- The company is reviewing various possibilities regarding its affiliate Inno Therapeutics from multiple angles, and nothing has been decided so far.
- Next disclosure date
- Dec 11, 2026Will re-disclose when confirmed or within 1 month
- Media outlet
- Seoul Economic Daily
- Report date
- Nov 11, 2026
Commentary
AI commentary · Not investment advice
What happened
Daewoong Pharmaceutical responded to a Seoul Economic Daily report that it is pursuing a sale of control of its affiliate, the drug developer INTherapeutics. The company said it is reviewing several possibilities from many angles. It said nothing has been decided so far.
In the company's terms
The company's answer is marked "unconfirmed." This means it has neither confirmed nor denied the report.
What changes for shareholders
The company will disclose again by 2026.12.11. If something is decided before then, it will disclose at that point. If nothing is decided, it will still disclose again within 1 month.
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist